ea0070aep696 | Pituitary and Neuroendocrinology | ECE2020
Rudman Yaron
, Duskin-Bitan Hadar
, Pertzov Barak
, Manisterski Yossi
, Masri-Iraqi Hiba
, Shimon Ilan
Objective: To study the outcomeof menwith macroprolactinoma followingcabergoline treatment based on tumor size.Design: A retrospective cohort study using a single tertiary referral center registry.Methods: The study included 96 men with macroprolctinoma, aged 16–84 years (mean 47.3 years) treated from 1993 to 2019,for a mean follow-up of 7.5 years. The cohort was subdivided into 3 groups according to baseline adenoma diameter...